— Know what they know.
Not Investment Advice

PDEX NASDAQ

Pro-Dex, Inc.
1W: +6.8% 1M: +23.4% 3M: +58.4% YTD: +66.0% 1Y: +40.5% 3Y: +295.0% 5Y: +78.9%
$63.52
+0.91 (+1.45%)
 
Weekly Expected Move ±7.8%
$50 $55 $59 $64 $69
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Strong Buy · Power 73 · $202.8M mcap · 2M float · 1.34% daily turnover · Short 46% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
47.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 18.3%  ·  5Y Avg: 17.5%
Cost Advantage ★
70
Intangibles
30
Switching Cost
50
Network Effect
34
Scale
55
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PDEX shows a Weak competitive edge (47.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 18.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
3
ROE
5
ROA
5
D/E
2
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PDEX receives an overall rating of B+. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 A- B+
2026-05-04 B+ A-
2026-05-01 A- B+
2026-04-27 B+ A-
2026-04-21 A- B+
2026-02-02 A A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

67 Grade A
Profitability
69
Balance Sheet
86
Earnings Quality
40
Growth
74
Value
64
Momentum
74
Safety
100
Cash Flow
55
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PDEX scores highest in Safety (100/100) and lowest in Earnings Quality (40/100). An overall grade of A places PDEX among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.62
Safe Zone
Piotroski F-Score
8/9
Beneish M-Score
-0.88
Possible Manipulator
Ohlson O-Score
-7.99
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 92.1/100
Trend: Improving
Earnings Quality
50/100
OCF/NI: 0.57x
Accruals: 8.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PDEX scores 6.62, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PDEX scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PDEX's score of -0.88 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PDEX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PDEX receives an estimated rating of AA+ (score: 92.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PDEX's score of 50/100 is moderate — some divergence between reported earnings and underlying cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
16.95x
PEG
0.58x
P/S
2.72x
P/B
4.50x
P/FCF
20.77x
P/OCF
19.67x
EV/EBITDA
7.86x
EV/Revenue
1.89x
EV/EBIT
8.47x
EV/FCF
22.31x
Earnings Yield
8.92%
FCF Yield
4.81%
Shareholder Yield
1.74%
Graham Number
$29.26
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 16.9x earnings, PDEX trades at a reasonable valuation. An earnings yield of 8.9% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $29.26 per share, 117% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.741
NI / EBT
×
Interest Burden
0.949
EBT / EBIT
×
EBIT Margin
0.224
EBIT / Rev
×
Asset Turnover
1.269
Rev / Assets
×
Equity Multiplier
1.684
Assets / Equity
=
ROE
33.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PDEX's ROE of 33.6% is driven by Asset Turnover (1.269), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
48.56%
Fair P/E
105.63x
Intrinsic Value
$362.46
Price/Value
0.11x
Margin of Safety
89.38%
Premium
-89.38%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PDEX's realized 48.6% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $362.46, PDEX appears undervalued with a 89% margin of safety. The adjusted fair P/E of 105.6x compares to the current market P/E of 16.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$63.52
Median 1Y
$64.91
5th Pctile
$23.84
95th Pctile
$176.23
Ann. Volatility
61.6%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Financial
ancial Officer
$— $— $12,879

CEO Pay Ratio

15:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $441,303
Avg Employee Cost (SGA/emp): $28,646
Employees: 181

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
181
+22.3% YoY
Revenue / Employee
$367,917
Rev: $66,593,000
Profit / Employee
$49,602
NI: $8,978,000
SGA / Employee
$28,646
Avg labor cost proxy
R&D / Employee
$20,088
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 34.1% 20.0% 19.1% 21.7% 14.9% 15.2% 15.2% 15.0% 19.6% 25.9% 19.9% 18.6% 15.2% 6.8% 16.7% 21.6% 30.0% 26.6% 33.2% 33.6% 33.59%
ROA 21.7% 11.1% 10.6% 12.1% 8.2% 7.9% 7.9% 7.8% 10.1% 14.6% 11.3% 10.5% 8.6% 4.1% 10.0% 12.9% 18.0% 15.8% 19.7% 19.9% 19.95%
ROIC 29.6% 9.5% 8.9% 10.6% 8.9% 10.5% 10.0% 9.0% 11.1% 10.3% 11.7% 11.2% 11.2% 15.4% 17.1% 21.1% 23.5% 17.3% 17.5% 18.3% 18.26%
ROCE 31.0% 15.8% 15.5% 17.6% 12.5% 13.7% 13.5% 13.5% 16.5% 14.8% 9.8% 8.5% 6.5% 8.1% 18.6% 23.7% 32.0% 27.7% 34.0% 34.6% 34.61%
Gross Margin 37.4% 33.1% 34.3% 33.5% 30.8% 27.3% 26.7% 23.2% 29.1% 31.6% 30.6% 22.3% 28.0% 27.2% 34.6% 30.2% 33.3% 19.9% 29.0% 30.8% 30.77%
Operating Margin 15.9% 6.3% 13.2% 15.7% 11.0% 9.4% 8.6% 10.1% 15.8% 15.1% 15.4% 6.2% 15.5% 15.6% 20.2% 16.0% 20.9% 7.7% 16.8% 17.5% 17.46%
Net Margin 17.0% 9.0% 10.7% 9.1% 5.0% 11.1% 9.7% 7.8% 12.4% 35.8% -5.2% 4.0% 4.6% 10.6% 16.6% 12.1% 18.8% 6.8% 25.3% 11.7% 11.72%
EBITDA Margin 24.5% 14.1% 16.8% 14.9% 10.0% 14.2% 14.6% 13.2% 16.1% 17.6% -3.5% 8.3% 9.4% 15.9% 25.3% 18.5% 20.9% 20.6% 36.3% 18.1% 18.13%
FCF Margin -19.3% -27.3% -19.2% -3.7% 7.5% -6.0% -3.8% -8.7% -3.4% 10.7% 7.8% 9.6% 13.0% 11.9% 11.3% 2.7% -2.7% -4.4% -3.0% 8.5% 8.49%
OCF Margin -0.4% -5.5% 3.8% 2.6% 13.3% -2.0% -1.5% -5.8% -0.9% 12.7% 10.3% 12.3% 15.6% 14.3% 13.5% 4.6% -0.8% -2.5% -1.8% 9.0% 8.96%
ROE 3Y Avg snapshot only 23.21%
ROE 5Y Avg snapshot only 20.73%
ROA 3Y Avg snapshot only 13.88%
ROIC 3Y Avg snapshot only 14.73%
ROIC Economic snapshot only 16.25%
Cash ROA snapshot only 10.56%
Cash ROIC snapshot only 14.03%
CROIC snapshot only 13.29%
NOPAT Margin snapshot only 11.67%
Pretax Margin snapshot only 21.22%
R&D / Revenue snapshot only 4.65%
SGA / Revenue snapshot only 7.89%
SBC / Revenue snapshot only 0.88%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 17.40 25.76 22.82 18.08 18.76 15.43 16.93 15.19 11.95 9.35 9.79 11.92 14.27 32.07 18.87 23.12 17.66 16.29 10.10 11.21 16.945
P/S Ratio 2.69 3.01 2.46 2.12 1.59 1.42 1.52 1.31 1.24 1.50 1.19 1.31 1.25 1.27 1.73 2.56 2.58 2.20 1.61 1.76 2.717
P/B Ratio 5.61 4.51 3.81 3.44 2.44 2.34 2.57 2.28 2.34 2.18 1.76 2.00 1.96 2.21 3.18 5.05 5.36 3.99 3.09 3.47 4.499
P/FCF -13.95 -11.04 -12.82 -57.22 21.14 -23.64 -39.80 -15.16 -36.36 14.00 15.18 13.61 9.68 10.65 15.34 95.31 -94.60 -49.94 -54.49 20.77 20.774
P/OCF 64.17 82.80 12.02 11.78 11.48 10.63 8.06 8.87 12.77 55.05 19.67 19.672
EV/EBITDA 12.08 19.34 16.87 13.76 14.01 12.51 13.67 12.44 10.54 11.24 13.13 16.06 18.95 17.22 12.29 15.35 13.34 11.02 7.17 7.86 7.863
EV/Revenue 2.64 3.39 2.82 2.46 1.96 1.76 1.85 1.64 1.54 1.73 1.41 1.53 1.47 1.39 1.85 2.67 2.68 2.34 1.74 1.89 1.894
EV/EBIT 13.07 21.58 18.97 15.30 16.21 14.29 15.64 14.26 11.84 12.78 16.14 20.72 26.70 23.46 14.26 17.33 13.61 12.08 7.73 8.47 8.473
EV/FCF -13.69 -12.42 -14.72 -66.62 26.04 -29.34 -48.53 -18.91 -45.15 16.17 18.10 15.92 11.36 11.69 16.39 99.40 -98.44 -53.15 -59.03 22.31 22.313
Earnings Yield 5.7% 3.9% 4.4% 5.5% 5.3% 6.5% 5.9% 6.6% 8.4% 10.7% 10.2% 8.4% 7.0% 3.1% 5.3% 4.3% 5.7% 6.1% 9.9% 8.9% 8.92%
FCF Yield -7.2% -9.1% -7.8% -1.7% 4.7% -4.2% -2.5% -6.6% -2.8% 7.1% 6.6% 7.3% 10.3% 9.4% 6.5% 1.0% -1.1% -2.0% -1.8% 4.8% 4.81%
PEG Ratio snapshot only 0.577
Price/Tangible Book snapshot only 3.473
EV/OCF snapshot only 21.129
EV/Gross Profit snapshot only 6.695
Acquirers Multiple snapshot only 12.029
Shareholder Yield snapshot only 1.74%
Graham Number snapshot only $29.26
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.34 2.74 2.74 2.74 2.74 2.74 2.74 2.74 2.74 3.20 3.20 3.20 3.20 2.84 2.84 2.84 2.84 3.23 3.23 3.23 3.233
Quick Ratio 2.76 1.63 1.63 1.63 1.63 1.63 1.63 1.63 1.63 1.53 1.53 1.53 1.53 1.66 1.66 1.66 1.66 1.71 1.71 1.71 1.715
Debt/Equity 0.37 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.47 0.47 0.47 0.47 0.44 0.44 0.44 0.44 0.45 0.45 0.45 0.453
Net Debt/Equity -0.10 0.56 0.56 0.56 0.56 0.56 0.56 0.56 0.56 0.34 0.34 0.34 0.34 0.22 0.22 0.22 0.22 0.26 0.26 0.26 0.257
Debt/Assets 0.23 0.33 0.33 0.33 0.33 0.33 0.33 0.33 0.33 0.29 0.29 0.29 0.29 0.26 0.26 0.26 0.26 0.27 0.27 0.27 0.271
Debt/EBITDA 0.81 2.39 2.42 2.16 2.93 2.70 2.73 2.74 2.28 2.09 2.93 3.21 3.85 3.11 1.59 1.28 1.05 1.17 0.97 0.95 0.955
Net Debt/EBITDA -0.23 2.15 2.18 1.94 2.64 2.43 2.46 2.47 2.05 1.51 2.12 2.33 2.79 1.54 0.78 0.63 0.52 0.67 0.55 0.54 0.542
Interest Coverage 27.98 16.98 14.04 14.46 10.02 11.14 10.77 10.47 12.37 11.70 7.68 6.53 4.92 5.71 12.73 14.60 16.84 15.55 18.06 19.80 19.800
Equity Multiplier 1.63 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.64 1.64 1.64 1.64 1.70 1.70 1.70 1.70 1.67 1.67 1.67 1.670
Cash Ratio snapshot only 0.489
Debt Service Coverage snapshot only 21.334
Cash to Debt snapshot only 0.432
FCF to Debt snapshot only 0.369
Defensive Interval snapshot only 994.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 1.40 0.95 0.98 1.03 0.97 0.86 0.88 0.90 0.98 0.91 0.93 0.96 0.98 1.03 1.09 1.17 1.23 1.17 1.24 1.27 1.269
Inventory Turnover 3.45 2.34 2.48 2.58 2.49 2.28 2.40 2.55 2.78 2.31 2.32 2.40 2.47 2.50 2.59 2.72 2.80 2.51 2.69 2.76 2.759
Receivables Turnover 8.58 3.70 3.84 4.03 3.78 2.73 2.80 2.88 3.12 3.64 3.71 3.81 3.90 4.52 4.77 5.12 5.38 4.39 4.63 4.76 4.756
Payables Turnover 12.61 8.54 9.05 9.43 9.10 7.69 8.10 8.61 9.37 11.07 11.12 11.50 11.84 11.60 12.03 12.60 13.00 10.32 11.07 11.33 11.330
DSO 43 99 95 91 96 134 130 127 117 100 99 96 93 81 77 71 68 83 79 77 76.7 days
DIO 106 156 147 141 147 160 152 143 131 158 157 152 148 146 141 134 130 145 135 132 132.3 days
DPO 29 43 40 39 40 47 45 42 39 33 33 32 31 31 30 29 28 35 33 32 32.2 days
Cash Conversion Cycle 119 212 202 193 203 246 237 227 209 225 223 216 210 195 187 177 170 193 181 177 176.8 days
Fixed Asset Turnover snapshot only 68.668
Operating Cycle snapshot only 209.0 days
Cash Velocity snapshot only 10.071
Capital Intensity snapshot only 0.849
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 29.3% 9.2% 9.0% 13.3% -2.2% 10.5% 9.4% 7.0% 23.7% 9.6% 8.8% 9.0% 2.9% 16.8% 21.0% 26.4% 29.7% 23.7% 23.7% 18.2% 18.19%
Net Income 37.9% -27.2% -32.3% -9.8% -46.2% -13.3% -9.0% -21.0% 50.6% 91.3% 47.0% 38.9% -12.7% -71.2% -8.4% 27.1% 1.2% 3.2% 1.1% 68.0% 68.02%
EPS 39.1% -20.4% -28.7% -3.9% -43.1% -12.9% -6.9% -18.5% 55.9% 97.8% 53.2% 40.4% -10.2% -70.0% -1.3% 37.6% 1.3% 3.4% 1.1% 69.7% 69.71%
FCF -5.4% -3.4% -4.0% 57.2% 1.4% 75.8% 78.3% -1.5% -1.6% 3.0% 3.2% 2.2% 4.9% 30.0% 74.6% -64.8% -1.3% -1.5% -1.3% 2.7% 2.74%
EBITDA 29.8% -23.1% -25.0% -3.5% -37.3% -11.5% -11.5% -21.3% 28.5% 20.1% -13.4% -20.9% -45.2% -38.6% 68.9% 1.3% 2.4% 2.2% 1.0% 63.9% 63.86%
Op. Income 1.6% -36.0% -39.7% -10.1% -26.2% 13.2% 10.8% -20.2% 17.7% 12.5% 39.7% 46.5% 20.6% 24.5% 25.7% 63.4% 81.8% 49.0% 29.1% 10.5% 10.55%
OCF Growth snapshot only 1.28%
Asset Growth snapshot only 16.61%
Equity Growth snapshot only 18.68%
Debt Growth snapshot only 22.37%
Shares Change snapshot only -1.00%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 22.1% 19.2% 17.6% 18.2% 13.7% 15.7% 16.2% 15.0% 16.1% 9.8% 9.1% 9.8% 7.6% 12.3% 12.9% 13.9% 18.2% 16.6% 17.6% 17.7% 17.67%
Revenue 5Y 16.0% 13.5% 12.9% 14.9% 12.1% 13.6% 14.4% 14.0% 17.1% 15.5% 14.2% 14.0% 13.4% 14.7% 15.6% 16.0% 15.9% 13.8% 14.2% 14.6% 14.59%
EPS 3Y 46.5% 47.6% 28.1% 19.7% 3.1% 1.4% 3.3% 2.2% 7.2% 11.1% 0.5% 3.2% -7.3% -19.8% 12.0% 16.3% 47.1% 37.4% 47.4% 48.6% 48.56%
EPS 5Y 55.8% 43.2% 30.2% 5.4% -4.7% -3.8% -4.2% 12.3% 22.8% 40.8% 24.5% 14.4% 8.9% -9.2% 10.7% 15.6% 20.3% 12.4% 16.3% 20.8% 20.76%
Net Income 3Y 41.5% 40.0% 22.0% 15.1% -1.2% -2.4% -0.3% -1.3% 3.8% 6.5% -3.2% -0.3% -10.9% -21.8% 7.0% 11.7% 41.5% 32.5% 42.5% 43.7% 43.69%
Net Income 5Y 54.1% 40.1% 28.1% 3.7% -6.2% -5.4% -6.5% 8.2% 18.1% 35.4% 19.4% 10.8% 4.9% -12.5% 5.9% 11.2% 16.0% 8.0% 12.3% 16.2% 16.16%
EBITDA 3Y 34.1% 18.0% 11.0% 11.1% -0.6% 2.5% 3.3% -0.1% 1.5% -6.5% -16.9% -15.6% -23.8% -13.3% 9.0% 12.7% 33.3% 33.7% 43.0% 43.9% 43.95%
EBITDA 5Y 44.2% 35.2% 27.4% 33.7% 14.3% 11.5% 8.3% 6.6% 14.2% 11.8% 0.9% -3.1% -7.1% -4.5% 10.0% 12.6% 14.0% 10.2% 14.2% 17.8% 17.77%
Gross Profit 3Y 25.0% 19.6% 15.4% 15.3% 10.0% 10.3% 8.8% 4.4% 4.0% -1.0% -0.9% 0.1% -2.1% 2.3% 5.8% 8.5% 16.2% 14.1% 15.9% 19.7% 19.74%
Gross Profit 5Y 23.7% 20.2% 17.8% 20.2% 13.4% 12.2% 10.7% 8.1% 11.2% 9.9% 8.8% 7.9% 7.5% 8.3% 10.3% 11.9% 12.0% 8.2% 7.4% 8.5% 8.49%
Op. Income 3Y 32.1% 24.0% 9.8% 9.6% 1.4% 0.8% -0.0% -6.4% -4.1% -6.6% -2.3% 1.7% 1.6% 16.6% 24.8% 24.1% 37.2% 27.8% 31.4% 38.3% 38.31%
Op. Income 5Y 72.9% 53.8% 35.6% 46.0% 16.5% 13.4% 7.6% 4.9% 14.9% 19.4% 15.4% 9.0% 8.1% 7.5% 11.9% 14.4% 14.1% 8.6% 8.6% 13.7% 13.69%
FCF 3Y -3.2% 4.0% 12.8%
FCF 5Y 2.2% 17.9% 20.8% 12.7% 14.7% 27.1% 19.7% -12.5%
OCF 3Y -17.5% -31.8% 5.5% 5.8% 15.5% 19.7% 72.0% 39.0%
OCF 5Y 2.2% -7.4% 8.5% 13.6% 12.5% 12.4% 11.9% 18.3% 16.4% -8.3% 13.2% 13.23%
Assets 3Y 23.9% 35.1% 35.1% 35.1% 35.1% 24.4% 24.4% 24.4% 24.4% 18.5% 18.5% 18.5% 18.5% 2.2% 2.2% 2.2% 2.2% 7.6% 7.6% 7.6% 7.62%
Assets 5Y 20.0% 34.5% 34.5% 34.5% 34.5% 24.6% 24.6% 24.6% 24.6% 21.1% 21.1% 21.1% 21.1% 15.5% 15.5% 15.5% 15.5% 14.5% 14.5% 14.5% 14.48%
Equity 3Y 11.6% 13.8% 13.8% 13.8% 13.8% 14.4% 14.4% 14.4% 14.4% 18.3% 18.3% 18.3% 18.3% 6.7% 6.7% 6.7% 6.7% 12.9% 12.9% 12.9% 12.94%
Book Value 3Y 15.6% 19.9% 19.4% 18.3% 18.7% 18.8% 18.5% 18.4% 18.2% 23.5% 22.9% 22.6% 23.1% 9.4% 11.7% 11.1% 10.9% 17.1% 16.8% 16.8% 16.77%
Dividend 3Y
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.88 0.90 0.89 0.94 0.91 0.97 0.97 0.98 0.95 0.98 0.98 0.98 0.94 0.99 0.98 0.95 0.93 0.91 0.89 0.91 0.913
Earnings Stability 0.61 0.38 0.30 0.47 0.07 0.02 0.00 0.43 0.34 0.50 0.31 0.34 0.03 0.04 0.05 0.40 0.27 0.05 0.35 0.55 0.551
Margin Stability 0.87 0.87 0.88 0.89 0.92 0.93 0.91 0.88 0.87 0.88 0.87 0.85 0.85 0.86 0.89 0.87 0.87 0.86 0.86 0.86 0.864
Rev. Growth Consistency 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 1
Earnings Persistence 0.85 0.89 0.87 0.96 0.82 0.95 0.96 0.92 0.50 0.50 0.81 0.84 0.95 0.50 0.97 0.89 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.68 0.69 0.62 0.90 0.40 0.86 0.91 0.77 0.60 0.37 0.62 0.67 0.86 0.00 0.91 0.76 0.27 0.00 0.27 0.49 0.492
ROE Trend 0.09 -0.11 -0.11 -0.07 -0.16 -0.10 -0.10 -0.09 -0.03 0.07 0.02 -0.00 -0.03 -0.12 0.00 0.06 0.14 0.09 0.13 0.12 0.116
Gross Margin Trend 0.00 -0.01 -0.03 -0.02 -0.04 -0.05 -0.07 -0.09 -0.08 -0.06 -0.03 -0.03 -0.02 -0.02 -0.01 0.02 0.04 0.02 -0.00 -0.01 -0.008
FCF Margin Trend -0.28 -0.37 -0.27 -0.04 0.14 0.01 0.02 -0.02 0.02 0.27 0.19 0.16 0.11 0.10 0.09 0.02 -0.08 -0.16 -0.12 0.02 0.023
Sustainable Growth Rate 34.1% 20.0% 19.1% 21.7% 14.9% 15.2% 15.2% 15.0% 19.6% 25.9% 19.9% 18.6% 15.2% 6.8% 16.7% 21.6% 30.0% 26.6% 33.2% 33.6% 33.59%
Internal Growth Rate 27.7% 12.5% 11.8% 13.7% 9.0% 8.5% 8.6% 8.4% 11.3% 17.1% 12.7% 11.8% 9.4% 4.3% 11.1% 14.9% 21.9% 18.8% 24.5% 24.9% 24.92%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.03 -0.47 0.36 0.22 1.56 -0.22 -0.17 -0.67 -0.09 0.79 0.85 1.12 1.77 3.62 1.48 0.42 -0.05 -0.19 -0.11 0.57 0.570
FCF/OCF 49.12 5.00 -5.01 -1.45 0.57 2.97 2.51 1.49 3.68 0.84 0.76 0.78 0.83 0.83 0.83 0.58 3.58 1.74 1.65 0.95 0.947
FCF/Net Income snapshot only 0.540
OCF/EBITDA snapshot only 0.372
CapEx/Revenue 18.9% 21.8% 23.0% 6.3% 5.7% 4.0% 2.3% 2.9% 2.5% 2.0% 2.5% 2.7% 2.6% 2.4% 2.3% 2.0% 2.0% 1.9% 1.2% 0.5% 0.48%
CapEx/Depreciation snapshot only 0.275
Accruals Ratio 0.22 0.16 0.07 0.09 -0.05 0.10 0.09 0.13 0.11 0.03 0.02 -0.01 -0.07 -0.11 -0.05 0.08 0.19 0.19 0.22 0.09 0.086
Sloan Accruals snapshot only 0.135
Cash Flow Adequacy snapshot only 18.843
Earnings Quality Score snapshot only 0.500
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 72.4% 1.2% 1.3% 1.3% 83.3% 41.6% 48.2% 59.7% 38.1% 43.7% 91.1% 80.8% 1.3% 2.7% 1.1% 1.0% 55.3% 39.0% 10.7% 19.5% 19.47%
Div. Increase Streak
Chowder Number
Buyback Yield 4.2% 4.8% 5.8% 7.1% 4.4% 2.7% 2.8% 3.9% 3.2% 4.7% 9.3% 6.8% 9.4% 8.5% 5.9% 4.4% 3.1% 2.4% 1.1% 1.7% 1.74%
Net Buyback Yield 4.2% 4.8% 5.8% 7.1% 4.4% 2.7% 2.8% 3.9% 3.2% 4.7% 9.3% 6.8% 9.4% 8.5% 5.9% 4.4% 3.1% 2.4% 1.0% 1.7% 1.68%
Total Shareholder Return 4.2% 4.8% 5.8% 7.1% 4.4% 2.7% 2.8% 3.9% 3.2% 4.7% 9.3% 6.8% 9.4% 8.5% 5.9% 4.4% 3.1% 2.4% 1.0% 1.7% 1.68%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.67 0.63 0.61 0.76 0.78 0.82 0.84 0.83 0.83 0.76 0.75 0.75 0.74 0.81 0.77 0.77 0.76 0.74 0.75 0.74 0.741
Interest Burden (EBT/EBIT) 1.14 1.18 1.19 0.95 0.90 0.91 0.91 0.90 0.97 1.56 1.85 1.98 2.16 0.82 0.92 0.93 0.98 0.94 0.94 0.95 0.949
EBIT Margin 0.20 0.16 0.15 0.16 0.12 0.12 0.12 0.11 0.13 0.14 0.09 0.07 0.06 0.06 0.13 0.15 0.20 0.19 0.23 0.22 0.224
Asset Turnover 1.40 0.95 0.98 1.03 0.97 0.86 0.88 0.90 0.98 0.91 0.93 0.96 0.98 1.03 1.09 1.17 1.23 1.17 1.24 1.27 1.269
Equity Multiplier 1.57 1.80 1.80 1.80 1.80 1.93 1.93 1.93 1.93 1.77 1.77 1.77 1.77 1.67 1.67 1.67 1.67 1.68 1.68 1.68 1.684
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $1.55 $1.19 $1.12 $1.28 $0.88 $1.03 $1.05 $1.05 $1.37 $2.04 $1.60 $1.47 $1.23 $0.61 $1.58 $2.02 $2.81 $2.68 $3.35 $3.43 $3.43
Book Value/Share $4.81 $6.78 $6.73 $6.75 $6.78 $6.82 $6.88 $6.96 $7.02 $8.75 $8.91 $8.75 $8.96 $8.89 $9.38 $9.25 $9.25 $10.93 $10.97 $11.09 $14.12
Tangible Book/Share $4.77 $6.75 $6.70 $6.72 $6.75 $6.78 $6.85 $6.93 $6.99 $8.73 $8.88 $8.72 $8.94 $8.87 $9.36 $9.23 $9.23 $10.93 $10.96 $11.08 $11.08
Revenue/Share $10.01 $10.14 $10.44 $10.97 $10.37 $11.27 $11.68 $12.12 $13.27 $12.77 $13.23 $13.36 $14.03 $15.50 $17.25 $18.28 $19.21 $19.88 $21.03 $21.82 $23.31
FCF/Share $-1.93 $-2.77 $-2.00 $-0.41 $0.78 $-0.67 $-0.45 $-1.05 $-0.45 $1.36 $1.03 $1.29 $1.82 $1.84 $1.95 $0.49 $-0.52 $-0.87 $-0.62 $1.85 $2.21
OCF/Share $-0.04 $-0.55 $0.40 $0.28 $1.38 $-0.23 $-0.18 $-0.70 $-0.12 $1.62 $1.37 $1.65 $2.18 $2.22 $2.34 $0.85 $-0.15 $-0.50 $-0.38 $1.96 $2.29
Cash/Share $2.26 $0.43 $0.42 $0.43 $0.43 $0.43 $0.43 $0.44 $0.44 $1.13 $1.15 $1.13 $1.15 $1.97 $2.08 $2.05 $2.05 $2.14 $2.14 $2.17 $3.43
EBITDA/Share $2.19 $1.78 $1.75 $1.96 $1.45 $1.58 $1.58 $1.59 $1.93 $1.96 $1.43 $1.28 $1.09 $1.25 $2.59 $3.18 $3.87 $4.22 $5.12 $5.26 $5.26
Debt/Share $1.77 $4.26 $4.23 $4.24 $4.26 $4.28 $4.32 $4.37 $4.41 $4.10 $4.17 $4.10 $4.20 $3.90 $4.11 $4.06 $4.06 $4.95 $4.96 $5.02 $5.02
Net Debt/Share $-0.49 $3.83 $3.80 $3.81 $3.83 $3.85 $3.89 $3.93 $3.96 $2.97 $3.02 $2.97 $3.04 $1.93 $2.03 $2.01 $2.01 $2.81 $2.82 $2.85 $2.85
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 6.616
Altman Z-Prime snapshot only 12.621
Piotroski F-Score 5 3 4 5 5 3 3 3 4 8 8 8 7 6 7 7 6 6 5 8 8
Beneish M-Score -0.72 0.50 -0.44 -0.49 -0.06 -1.83 -1.87 -1.59 -1.77 -2.47 -2.49 -2.55 -2.77 -2.70 -2.67 -2.14 -1.58 -0.25 -0.16 -0.88 -0.884
Ohlson O-Score snapshot only -7.990
ROIC (Greenblatt) snapshot only 47.80%
Net-Net WC snapshot only $6.88
EVA snapshot only $3805702.22
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA+
Credit Score 82.31 76.61 75.09 76.20 77.35 73.06 73.61 74.41 74.28 86.84 79.36 80.72 77.32 80.31 87.96 85.28 82.10 82.92 84.37 92.09 92.094
Credit Grade snapshot only 2
Credit Trend snapshot only 6.816
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 82
Sector Credit Rank snapshot only 89

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms